nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP3A7—Paclitaxel—ovarian cancer	0.0722	0.128	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0722	0.128	CbGbCtD
Zolpidem—CYP3A5—Paclitaxel—ovarian cancer	0.0542	0.096	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0522	0.0925	CbGbCtD
Zolpidem—CYP3A7—Docetaxel—ovarian cancer	0.0522	0.0925	CbGbCtD
Zolpidem—CYP2D6—Vinorelbine—ovarian cancer	0.0473	0.0838	CbGbCtD
Zolpidem—CYP3A4—Topotecan—ovarian cancer	0.0427	0.0756	CbGbCtD
Zolpidem—CYP3A5—Docetaxel—ovarian cancer	0.0392	0.0694	CbGbCtD
Zolpidem—CYP2C9—Paclitaxel—ovarian cancer	0.0363	0.0644	CbGbCtD
Zolpidem—CYP3A4—Vinorelbine—ovarian cancer	0.0301	0.0533	CbGbCtD
Zolpidem—CYP3A4—Paclitaxel—ovarian cancer	0.0211	0.0374	CbGbCtD
Zolpidem—CYP2D6—Doxorubicin—ovarian cancer	0.0179	0.0317	CbGbCtD
Zolpidem—CYP3A4—Docetaxel—ovarian cancer	0.0153	0.0271	CbGbCtD
Zolpidem—CYP3A4—Doxorubicin—ovarian cancer	0.0114	0.0202	CbGbCtD
Zolpidem—Tolmetin—CXCL8—ovarian cancer	0.00804	1	CrCbGaD
Zolpidem—Paraesthesia—Paclitaxel—ovarian cancer	0.000245	0.000598	CcSEcCtD
Zolpidem—Hypertension—Docetaxel—ovarian cancer	0.000245	0.000597	CcSEcCtD
Zolpidem—Infestation NOS—Epirubicin—ovarian cancer	0.000245	0.000597	CcSEcCtD
Zolpidem—Infestation—Epirubicin—ovarian cancer	0.000245	0.000597	CcSEcCtD
Zolpidem—Drowsiness—Epirubicin—ovarian cancer	0.000245	0.000597	CcSEcCtD
Zolpidem—Bronchitis—Doxorubicin—ovarian cancer	0.000244	0.000596	CcSEcCtD
Zolpidem—Dyspnoea—Paclitaxel—ovarian cancer	0.000244	0.000594	CcSEcCtD
Zolpidem—Somnolence—Paclitaxel—ovarian cancer	0.000243	0.000592	CcSEcCtD
Zolpidem—Chest pain—Docetaxel—ovarian cancer	0.000242	0.000589	CcSEcCtD
Zolpidem—Arthralgia—Docetaxel—ovarian cancer	0.000242	0.000589	CcSEcCtD
Zolpidem—Myalgia—Docetaxel—ovarian cancer	0.000242	0.000589	CcSEcCtD
Zolpidem—Nausea—Vinorelbine—ovarian cancer	0.000241	0.000588	CcSEcCtD
Zolpidem—Dyspepsia—Paclitaxel—ovarian cancer	0.00024	0.000586	CcSEcCtD
Zolpidem—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00024	0.000585	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00024	0.000585	CcSEcCtD
Zolpidem—Stomatitis—Epirubicin—ovarian cancer	0.000239	0.000582	CcSEcCtD
Zolpidem—Conjunctivitis—Epirubicin—ovarian cancer	0.000238	0.00058	CcSEcCtD
Zolpidem—Urinary tract infection—Epirubicin—ovarian cancer	0.000238	0.00058	CcSEcCtD
Zolpidem—Dysuria—Doxorubicin—ovarian cancer	0.000238	0.000579	CcSEcCtD
Zolpidem—Decreased appetite—Paclitaxel—ovarian cancer	0.000237	0.000579	CcSEcCtD
Zolpidem—Dry mouth—Docetaxel—ovarian cancer	0.000236	0.000576	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000236	0.000576	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000236	0.000575	CcSEcCtD
Zolpidem—Fatigue—Paclitaxel—ovarian cancer	0.000236	0.000574	CcSEcCtD
Zolpidem—Pollakiuria—Doxorubicin—ovarian cancer	0.000235	0.000572	CcSEcCtD
Zolpidem—Pain—Paclitaxel—ovarian cancer	0.000234	0.000569	CcSEcCtD
Zolpidem—Constipation—Paclitaxel—ovarian cancer	0.000234	0.000569	CcSEcCtD
Zolpidem—Confusional state—Docetaxel—ovarian cancer	0.000233	0.000569	CcSEcCtD
Zolpidem—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000232	0.000565	CcSEcCtD
Zolpidem—Anaphylactic shock—Docetaxel—ovarian cancer	0.000232	0.000564	CcSEcCtD
Zolpidem—Oedema—Docetaxel—ovarian cancer	0.000232	0.000564	CcSEcCtD
Zolpidem—Epistaxis—Epirubicin—ovarian cancer	0.000231	0.000563	CcSEcCtD
Zolpidem—Infection—Docetaxel—ovarian cancer	0.00023	0.000561	CcSEcCtD
Zolpidem—Weight decreased—Doxorubicin—ovarian cancer	0.00023	0.00056	CcSEcCtD
Zolpidem—Sinusitis—Epirubicin—ovarian cancer	0.00023	0.00056	CcSEcCtD
Zolpidem—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000229	0.000559	CcSEcCtD
Zolpidem—Pneumonia—Doxorubicin—ovarian cancer	0.000228	0.000555	CcSEcCtD
Zolpidem—Shock—Docetaxel—ovarian cancer	0.000228	0.000555	CcSEcCtD
Zolpidem—Nervous system disorder—Docetaxel—ovarian cancer	0.000227	0.000553	CcSEcCtD
Zolpidem—Infestation NOS—Doxorubicin—ovarian cancer	0.000227	0.000552	CcSEcCtD
Zolpidem—Infestation—Doxorubicin—ovarian cancer	0.000227	0.000552	CcSEcCtD
Zolpidem—Drowsiness—Doxorubicin—ovarian cancer	0.000227	0.000552	CcSEcCtD
Zolpidem—Tachycardia—Docetaxel—ovarian cancer	0.000226	0.000551	CcSEcCtD
Zolpidem—Feeling abnormal—Paclitaxel—ovarian cancer	0.000225	0.000549	CcSEcCtD
Zolpidem—Skin disorder—Docetaxel—ovarian cancer	0.000225	0.000548	CcSEcCtD
Zolpidem—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000223	0.000544	CcSEcCtD
Zolpidem—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000222	0.000541	CcSEcCtD
Zolpidem—Stomatitis—Doxorubicin—ovarian cancer	0.000221	0.000538	CcSEcCtD
Zolpidem—Anorexia—Docetaxel—ovarian cancer	0.000221	0.000538	CcSEcCtD
Zolpidem—Rhinitis—Epirubicin—ovarian cancer	0.00022	0.000537	CcSEcCtD
Zolpidem—Conjunctivitis—Doxorubicin—ovarian cancer	0.00022	0.000537	CcSEcCtD
Zolpidem—Urinary tract infection—Doxorubicin—ovarian cancer	0.00022	0.000537	CcSEcCtD
Zolpidem—Hypoaesthesia—Epirubicin—ovarian cancer	0.000219	0.000533	CcSEcCtD
Zolpidem—Pharyngitis—Epirubicin—ovarian cancer	0.000218	0.000532	CcSEcCtD
Zolpidem—Urinary tract disorder—Epirubicin—ovarian cancer	0.000217	0.000529	CcSEcCtD
Zolpidem—Urticaria—Paclitaxel—ovarian cancer	0.000217	0.000529	CcSEcCtD
Zolpidem—Hypotension—Docetaxel—ovarian cancer	0.000216	0.000527	CcSEcCtD
Zolpidem—Connective tissue disorder—Epirubicin—ovarian cancer	0.000216	0.000527	CcSEcCtD
Zolpidem—Abdominal pain—Paclitaxel—ovarian cancer	0.000216	0.000526	CcSEcCtD
Zolpidem—Body temperature increased—Paclitaxel—ovarian cancer	0.000216	0.000526	CcSEcCtD
Zolpidem—Urethral disorder—Epirubicin—ovarian cancer	0.000216	0.000525	CcSEcCtD
Zolpidem—Epistaxis—Doxorubicin—ovarian cancer	0.000214	0.000521	CcSEcCtD
Zolpidem—Sinusitis—Doxorubicin—ovarian cancer	0.000213	0.000518	CcSEcCtD
Zolpidem—Visual impairment—Epirubicin—ovarian cancer	0.000212	0.000516	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000211	0.000514	CcSEcCtD
Zolpidem—Insomnia—Docetaxel—ovarian cancer	0.000209	0.00051	CcSEcCtD
Zolpidem—Paraesthesia—Docetaxel—ovarian cancer	0.000208	0.000507	CcSEcCtD
Zolpidem—Dyspnoea—Docetaxel—ovarian cancer	0.000206	0.000503	CcSEcCtD
Zolpidem—Somnolence—Docetaxel—ovarian cancer	0.000206	0.000502	CcSEcCtD
Zolpidem—Eye disorder—Epirubicin—ovarian cancer	0.000205	0.000501	CcSEcCtD
Zolpidem—Tinnitus—Epirubicin—ovarian cancer	0.000205	0.0005	CcSEcCtD
Zolpidem—Cardiac disorder—Epirubicin—ovarian cancer	0.000204	0.000497	CcSEcCtD
Zolpidem—Flushing—Epirubicin—ovarian cancer	0.000204	0.000497	CcSEcCtD
Zolpidem—Rhinitis—Doxorubicin—ovarian cancer	0.000204	0.000497	CcSEcCtD
Zolpidem—Dyspepsia—Docetaxel—ovarian cancer	0.000204	0.000497	CcSEcCtD
Zolpidem—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000202	0.000493	CcSEcCtD
Zolpidem—Pharyngitis—Doxorubicin—ovarian cancer	0.000202	0.000492	CcSEcCtD
Zolpidem—Decreased appetite—Docetaxel—ovarian cancer	0.000201	0.000491	CcSEcCtD
Zolpidem—Hypersensitivity—Paclitaxel—ovarian cancer	0.000201	0.000491	CcSEcCtD
Zolpidem—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000201	0.00049	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.0002	0.000487	CcSEcCtD
Zolpidem—Connective tissue disorder—Doxorubicin—ovarian cancer	0.0002	0.000487	CcSEcCtD
Zolpidem—Fatigue—Docetaxel—ovarian cancer	0.0002	0.000487	CcSEcCtD
Zolpidem—Urethral disorder—Doxorubicin—ovarian cancer	0.000199	0.000486	CcSEcCtD
Zolpidem—Mediastinal disorder—Epirubicin—ovarian cancer	0.000198	0.000483	CcSEcCtD
Zolpidem—Pain—Docetaxel—ovarian cancer	0.000198	0.000483	CcSEcCtD
Zolpidem—Constipation—Docetaxel—ovarian cancer	0.000198	0.000483	CcSEcCtD
Zolpidem—Chills—Epirubicin—ovarian cancer	0.000197	0.000481	CcSEcCtD
Zolpidem—Arrhythmia—Epirubicin—ovarian cancer	0.000196	0.000479	CcSEcCtD
Zolpidem—Visual impairment—Doxorubicin—ovarian cancer	0.000196	0.000478	CcSEcCtD
Zolpidem—Asthenia—Paclitaxel—ovarian cancer	0.000196	0.000478	CcSEcCtD
Zolpidem—Pruritus—Paclitaxel—ovarian cancer	0.000193	0.000471	CcSEcCtD
Zolpidem—Mental disorder—Epirubicin—ovarian cancer	0.000193	0.000469	CcSEcCtD
Zolpidem—Malnutrition—Epirubicin—ovarian cancer	0.000191	0.000466	CcSEcCtD
Zolpidem—Erythema—Epirubicin—ovarian cancer	0.000191	0.000466	CcSEcCtD
Zolpidem—Feeling abnormal—Docetaxel—ovarian cancer	0.000191	0.000465	CcSEcCtD
Zolpidem—Eye disorder—Doxorubicin—ovarian cancer	0.00019	0.000463	CcSEcCtD
Zolpidem—Tinnitus—Doxorubicin—ovarian cancer	0.00019	0.000462	CcSEcCtD
Zolpidem—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000189	0.000461	CcSEcCtD
Zolpidem—Cardiac disorder—Doxorubicin—ovarian cancer	0.000189	0.00046	CcSEcCtD
Zolpidem—Flushing—Doxorubicin—ovarian cancer	0.000189	0.00046	CcSEcCtD
Zolpidem—Flatulence—Epirubicin—ovarian cancer	0.000189	0.00046	CcSEcCtD
Zolpidem—Tension—Epirubicin—ovarian cancer	0.000188	0.000458	CcSEcCtD
Zolpidem—Dysgeusia—Epirubicin—ovarian cancer	0.000187	0.000457	CcSEcCtD
Zolpidem—Diarrhoea—Paclitaxel—ovarian cancer	0.000187	0.000456	CcSEcCtD
Zolpidem—Nervousness—Epirubicin—ovarian cancer	0.000186	0.000453	CcSEcCtD
Zolpidem—Back pain—Epirubicin—ovarian cancer	0.000185	0.000451	CcSEcCtD
Zolpidem—Muscle spasms—Epirubicin—ovarian cancer	0.000184	0.000448	CcSEcCtD
Zolpidem—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000183	0.000447	CcSEcCtD
Zolpidem—Body temperature increased—Docetaxel—ovarian cancer	0.000183	0.000446	CcSEcCtD
Zolpidem—Abdominal pain—Docetaxel—ovarian cancer	0.000183	0.000446	CcSEcCtD
Zolpidem—Chills—Doxorubicin—ovarian cancer	0.000183	0.000445	CcSEcCtD
Zolpidem—Arrhythmia—Doxorubicin—ovarian cancer	0.000182	0.000443	CcSEcCtD
Zolpidem—Dizziness—Paclitaxel—ovarian cancer	0.000181	0.00044	CcSEcCtD
Zolpidem—Vision blurred—Epirubicin—ovarian cancer	0.00018	0.00044	CcSEcCtD
Zolpidem—Mental disorder—Doxorubicin—ovarian cancer	0.000178	0.000434	CcSEcCtD
Zolpidem—Ill-defined disorder—Epirubicin—ovarian cancer	0.000178	0.000433	CcSEcCtD
Zolpidem—Erythema—Doxorubicin—ovarian cancer	0.000177	0.000432	CcSEcCtD
Zolpidem—Malnutrition—Doxorubicin—ovarian cancer	0.000177	0.000432	CcSEcCtD
Zolpidem—Anaemia—Epirubicin—ovarian cancer	0.000177	0.000431	CcSEcCtD
Zolpidem—Agitation—Epirubicin—ovarian cancer	0.000176	0.000429	CcSEcCtD
Zolpidem—Flatulence—Doxorubicin—ovarian cancer	0.000174	0.000425	CcSEcCtD
Zolpidem—Tension—Doxorubicin—ovarian cancer	0.000174	0.000423	CcSEcCtD
Zolpidem—Vomiting—Paclitaxel—ovarian cancer	0.000174	0.000423	CcSEcCtD
Zolpidem—Dysgeusia—Doxorubicin—ovarian cancer	0.000173	0.000423	CcSEcCtD
Zolpidem—Malaise—Epirubicin—ovarian cancer	0.000173	0.000421	CcSEcCtD
Zolpidem—Rash—Paclitaxel—ovarian cancer	0.000172	0.00042	CcSEcCtD
Zolpidem—Dermatitis—Paclitaxel—ovarian cancer	0.000172	0.000419	CcSEcCtD
Zolpidem—Nervousness—Doxorubicin—ovarian cancer	0.000172	0.000419	CcSEcCtD
Zolpidem—Vertigo—Epirubicin—ovarian cancer	0.000172	0.000419	CcSEcCtD
Zolpidem—Syncope—Epirubicin—ovarian cancer	0.000172	0.000418	CcSEcCtD
Zolpidem—Leukopenia—Epirubicin—ovarian cancer	0.000171	0.000418	CcSEcCtD
Zolpidem—Back pain—Doxorubicin—ovarian cancer	0.000171	0.000417	CcSEcCtD
Zolpidem—Headache—Paclitaxel—ovarian cancer	0.000171	0.000417	CcSEcCtD
Zolpidem—Hypersensitivity—Docetaxel—ovarian cancer	0.000171	0.000416	CcSEcCtD
Zolpidem—Muscle spasms—Doxorubicin—ovarian cancer	0.00017	0.000415	CcSEcCtD
Zolpidem—Palpitations—Epirubicin—ovarian cancer	0.000169	0.000412	CcSEcCtD
Zolpidem—Loss of consciousness—Epirubicin—ovarian cancer	0.000168	0.00041	CcSEcCtD
Zolpidem—Cough—Epirubicin—ovarian cancer	0.000167	0.000407	CcSEcCtD
Zolpidem—Vision blurred—Doxorubicin—ovarian cancer	0.000167	0.000407	CcSEcCtD
Zolpidem—Asthenia—Docetaxel—ovarian cancer	0.000166	0.000405	CcSEcCtD
Zolpidem—Hypertension—Epirubicin—ovarian cancer	0.000165	0.000403	CcSEcCtD
Zolpidem—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000164	0.0004	CcSEcCtD
Zolpidem—Pruritus—Docetaxel—ovarian cancer	0.000164	0.000399	CcSEcCtD
Zolpidem—Anaemia—Doxorubicin—ovarian cancer	0.000164	0.000399	CcSEcCtD
Zolpidem—Arthralgia—Epirubicin—ovarian cancer	0.000163	0.000397	CcSEcCtD
Zolpidem—Chest pain—Epirubicin—ovarian cancer	0.000163	0.000397	CcSEcCtD
Zolpidem—Myalgia—Epirubicin—ovarian cancer	0.000163	0.000397	CcSEcCtD
Zolpidem—Agitation—Doxorubicin—ovarian cancer	0.000163	0.000397	CcSEcCtD
Zolpidem—Anxiety—Epirubicin—ovarian cancer	0.000162	0.000396	CcSEcCtD
Zolpidem—Nausea—Paclitaxel—ovarian cancer	0.000162	0.000395	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000162	0.000394	CcSEcCtD
Zolpidem—Discomfort—Epirubicin—ovarian cancer	0.000161	0.000392	CcSEcCtD
Zolpidem—Malaise—Doxorubicin—ovarian cancer	0.00016	0.000389	CcSEcCtD
Zolpidem—Dry mouth—Epirubicin—ovarian cancer	0.000159	0.000388	CcSEcCtD
Zolpidem—Vertigo—Doxorubicin—ovarian cancer	0.000159	0.000388	CcSEcCtD
Zolpidem—Syncope—Doxorubicin—ovarian cancer	0.000159	0.000387	CcSEcCtD
Zolpidem—Leukopenia—Doxorubicin—ovarian cancer	0.000159	0.000386	CcSEcCtD
Zolpidem—Diarrhoea—Docetaxel—ovarian cancer	0.000158	0.000386	CcSEcCtD
Zolpidem—Confusional state—Epirubicin—ovarian cancer	0.000157	0.000384	CcSEcCtD
Zolpidem—Palpitations—Doxorubicin—ovarian cancer	0.000156	0.000381	CcSEcCtD
Zolpidem—Anaphylactic shock—Epirubicin—ovarian cancer	0.000156	0.000381	CcSEcCtD
Zolpidem—Oedema—Epirubicin—ovarian cancer	0.000156	0.000381	CcSEcCtD
Zolpidem—Loss of consciousness—Doxorubicin—ovarian cancer	0.000156	0.000379	CcSEcCtD
Zolpidem—Infection—Epirubicin—ovarian cancer	0.000155	0.000378	CcSEcCtD
Zolpidem—Cough—Doxorubicin—ovarian cancer	0.000155	0.000377	CcSEcCtD
Zolpidem—Shock—Epirubicin—ovarian cancer	0.000154	0.000375	CcSEcCtD
Zolpidem—Nervous system disorder—Epirubicin—ovarian cancer	0.000153	0.000373	CcSEcCtD
Zolpidem—Dizziness—Docetaxel—ovarian cancer	0.000153	0.000373	CcSEcCtD
Zolpidem—Hypertension—Doxorubicin—ovarian cancer	0.000153	0.000373	CcSEcCtD
Zolpidem—Tachycardia—Epirubicin—ovarian cancer	0.000152	0.000372	CcSEcCtD
Zolpidem—Skin disorder—Epirubicin—ovarian cancer	0.000152	0.00037	CcSEcCtD
Zolpidem—Hyperhidrosis—Epirubicin—ovarian cancer	0.000151	0.000368	CcSEcCtD
Zolpidem—Chest pain—Doxorubicin—ovarian cancer	0.000151	0.000367	CcSEcCtD
Zolpidem—Arthralgia—Doxorubicin—ovarian cancer	0.000151	0.000367	CcSEcCtD
Zolpidem—Myalgia—Doxorubicin—ovarian cancer	0.000151	0.000367	CcSEcCtD
Zolpidem—Anxiety—Doxorubicin—ovarian cancer	0.00015	0.000366	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00015	0.000365	CcSEcCtD
Zolpidem—Discomfort—Doxorubicin—ovarian cancer	0.000149	0.000363	CcSEcCtD
Zolpidem—Anorexia—Epirubicin—ovarian cancer	0.000149	0.000363	CcSEcCtD
Zolpidem—Dry mouth—Doxorubicin—ovarian cancer	0.000147	0.000359	CcSEcCtD
Zolpidem—Vomiting—Docetaxel—ovarian cancer	0.000147	0.000359	CcSEcCtD
Zolpidem—Rash—Docetaxel—ovarian cancer	0.000146	0.000356	CcSEcCtD
Zolpidem—Hypotension—Epirubicin—ovarian cancer	0.000146	0.000356	CcSEcCtD
Zolpidem—Dermatitis—Docetaxel—ovarian cancer	0.000146	0.000356	CcSEcCtD
Zolpidem—Confusional state—Doxorubicin—ovarian cancer	0.000146	0.000355	CcSEcCtD
Zolpidem—Headache—Docetaxel—ovarian cancer	0.000145	0.000354	CcSEcCtD
Zolpidem—Oedema—Doxorubicin—ovarian cancer	0.000145	0.000352	CcSEcCtD
Zolpidem—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000145	0.000352	CcSEcCtD
Zolpidem—Infection—Doxorubicin—ovarian cancer	0.000144	0.00035	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000142	0.000347	CcSEcCtD
Zolpidem—Shock—Doxorubicin—ovarian cancer	0.000142	0.000347	CcSEcCtD
Zolpidem—Nervous system disorder—Doxorubicin—ovarian cancer	0.000142	0.000345	CcSEcCtD
Zolpidem—Insomnia—Epirubicin—ovarian cancer	0.000141	0.000344	CcSEcCtD
Zolpidem—Tachycardia—Doxorubicin—ovarian cancer	0.000141	0.000344	CcSEcCtD
Zolpidem—Skin disorder—Doxorubicin—ovarian cancer	0.00014	0.000342	CcSEcCtD
Zolpidem—Paraesthesia—Epirubicin—ovarian cancer	0.00014	0.000342	CcSEcCtD
Zolpidem—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00014	0.00034	CcSEcCtD
Zolpidem—Dyspnoea—Epirubicin—ovarian cancer	0.000139	0.000339	CcSEcCtD
Zolpidem—Somnolence—Epirubicin—ovarian cancer	0.000139	0.000338	CcSEcCtD
Zolpidem—Anorexia—Doxorubicin—ovarian cancer	0.000138	0.000336	CcSEcCtD
Zolpidem—Nausea—Docetaxel—ovarian cancer	0.000138	0.000335	CcSEcCtD
Zolpidem—Dyspepsia—Epirubicin—ovarian cancer	0.000137	0.000335	CcSEcCtD
Zolpidem—Decreased appetite—Epirubicin—ovarian cancer	0.000136	0.000331	CcSEcCtD
Zolpidem—Hypotension—Doxorubicin—ovarian cancer	0.000135	0.000329	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000135	0.000329	CcSEcCtD
Zolpidem—Fatigue—Epirubicin—ovarian cancer	0.000135	0.000328	CcSEcCtD
Zolpidem—Pain—Epirubicin—ovarian cancer	0.000134	0.000326	CcSEcCtD
Zolpidem—Constipation—Epirubicin—ovarian cancer	0.000134	0.000326	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000132	0.000321	CcSEcCtD
Zolpidem—Insomnia—Doxorubicin—ovarian cancer	0.000131	0.000319	CcSEcCtD
Zolpidem—Paraesthesia—Doxorubicin—ovarian cancer	0.00013	0.000316	CcSEcCtD
Zolpidem—Dyspnoea—Doxorubicin—ovarian cancer	0.000129	0.000314	CcSEcCtD
Zolpidem—Feeling abnormal—Epirubicin—ovarian cancer	0.000129	0.000314	CcSEcCtD
Zolpidem—Somnolence—Doxorubicin—ovarian cancer	0.000128	0.000313	CcSEcCtD
Zolpidem—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000128	0.000311	CcSEcCtD
Zolpidem—Dyspepsia—Doxorubicin—ovarian cancer	0.000127	0.00031	CcSEcCtD
Zolpidem—Decreased appetite—Doxorubicin—ovarian cancer	0.000126	0.000306	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000125	0.000304	CcSEcCtD
Zolpidem—Fatigue—Doxorubicin—ovarian cancer	0.000125	0.000304	CcSEcCtD
Zolpidem—Urticaria—Epirubicin—ovarian cancer	0.000124	0.000302	CcSEcCtD
Zolpidem—Pain—Doxorubicin—ovarian cancer	0.000124	0.000301	CcSEcCtD
Zolpidem—Constipation—Doxorubicin—ovarian cancer	0.000124	0.000301	CcSEcCtD
Zolpidem—Body temperature increased—Epirubicin—ovarian cancer	0.000123	0.000301	CcSEcCtD
Zolpidem—Abdominal pain—Epirubicin—ovarian cancer	0.000123	0.000301	CcSEcCtD
Zolpidem—Feeling abnormal—Doxorubicin—ovarian cancer	0.000119	0.00029	CcSEcCtD
Zolpidem—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000118	0.000288	CcSEcCtD
Zolpidem—Hypersensitivity—Epirubicin—ovarian cancer	0.000115	0.00028	CcSEcCtD
Zolpidem—Urticaria—Doxorubicin—ovarian cancer	0.000115	0.00028	CcSEcCtD
Zolpidem—Body temperature increased—Doxorubicin—ovarian cancer	0.000114	0.000278	CcSEcCtD
Zolpidem—Abdominal pain—Doxorubicin—ovarian cancer	0.000114	0.000278	CcSEcCtD
Zolpidem—Asthenia—Epirubicin—ovarian cancer	0.000112	0.000273	CcSEcCtD
Zolpidem—Pruritus—Epirubicin—ovarian cancer	0.000111	0.000269	CcSEcCtD
Zolpidem—Diarrhoea—Epirubicin—ovarian cancer	0.000107	0.00026	CcSEcCtD
Zolpidem—Hypersensitivity—Doxorubicin—ovarian cancer	0.000106	0.000259	CcSEcCtD
Zolpidem—Asthenia—Doxorubicin—ovarian cancer	0.000104	0.000253	CcSEcCtD
Zolpidem—Dizziness—Epirubicin—ovarian cancer	0.000103	0.000252	CcSEcCtD
Zolpidem—Pruritus—Doxorubicin—ovarian cancer	0.000102	0.000249	CcSEcCtD
Zolpidem—Vomiting—Epirubicin—ovarian cancer	9.93e-05	0.000242	CcSEcCtD
Zolpidem—Diarrhoea—Doxorubicin—ovarian cancer	9.89e-05	0.000241	CcSEcCtD
Zolpidem—Rash—Epirubicin—ovarian cancer	9.85e-05	0.00024	CcSEcCtD
Zolpidem—Dermatitis—Epirubicin—ovarian cancer	9.84e-05	0.00024	CcSEcCtD
Zolpidem—Headache—Epirubicin—ovarian cancer	9.79e-05	0.000238	CcSEcCtD
Zolpidem—Dizziness—Doxorubicin—ovarian cancer	9.56e-05	0.000233	CcSEcCtD
Zolpidem—Nausea—Epirubicin—ovarian cancer	9.28e-05	0.000226	CcSEcCtD
Zolpidem—Vomiting—Doxorubicin—ovarian cancer	9.19e-05	0.000224	CcSEcCtD
Zolpidem—Rash—Doxorubicin—ovarian cancer	9.11e-05	0.000222	CcSEcCtD
Zolpidem—Dermatitis—Doxorubicin—ovarian cancer	9.1e-05	0.000222	CcSEcCtD
Zolpidem—Headache—Doxorubicin—ovarian cancer	9.05e-05	0.000221	CcSEcCtD
Zolpidem—Nausea—Doxorubicin—ovarian cancer	8.58e-05	0.000209	CcSEcCtD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.45e-05	0.0014	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.43e-05	0.00139	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	2.42e-05	0.00138	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.42e-05	0.00138	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.39e-05	0.00136	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	2.38e-05	0.00136	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	2.26e-05	0.00129	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NME2—ovarian cancer	2.25e-05	0.00128	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	2.24e-05	0.00128	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	2.22e-05	0.00127	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2.2e-05	0.00125	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	2.19e-05	0.00125	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.19e-05	0.00125	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	2.13e-05	0.00122	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.11e-05	0.00121	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2.1e-05	0.0012	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	2.09e-05	0.00119	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.08e-05	0.00119	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.08e-05	0.00119	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	2.08e-05	0.00119	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	2.07e-05	0.00118	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	2.04e-05	0.00116	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	2.04e-05	0.00116	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	2.04e-05	0.00116	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	2e-05	0.00114	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYTB—ovarian cancer	2e-05	0.00114	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	2e-05	0.00114	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.99e-05	0.00114	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	1.97e-05	0.00112	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.96e-05	0.00112	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.95e-05	0.00112	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	1.95e-05	0.00112	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.94e-05	0.00111	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYTB—ovarian cancer	1.94e-05	0.00111	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	1.92e-05	0.0011	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	1.92e-05	0.0011	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	1.91e-05	0.00109	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.91e-05	0.00109	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.9e-05	0.00108	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.87e-05	0.00107	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.84e-05	0.00105	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.83e-05	0.00104	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.8e-05	0.00103	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PPP1CC—ovarian cancer	1.75e-05	0.001	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—BRIP1—ovarian cancer	1.75e-05	0.001	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NME2—ovarian cancer	1.74e-05	0.000992	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	1.71e-05	0.000978	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.71e-05	0.000978	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PPP1CC—ovarian cancer	1.7e-05	0.000969	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—BRIP1—ovarian cancer	1.7e-05	0.000969	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	1.69e-05	0.000965	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	1.69e-05	0.000963	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	1.68e-05	0.000958	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.67e-05	0.000952	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	1.64e-05	0.000934	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NME2—ovarian cancer	1.6e-05	0.000912	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NME2—ovarian cancer	1.58e-05	0.000904	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.58e-05	0.0009	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	1.57e-05	0.000897	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—MAPK1—ovarian cancer	1.5e-05	0.000859	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.5e-05	0.000859	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.48e-05	0.000844	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.47e-05	0.000841	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	1.47e-05	0.00084	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.47e-05	0.000839	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYTB—ovarian cancer	1.45e-05	0.000827	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.44e-05	0.000824	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—MAPK1—ovarian cancer	1.44e-05	0.00082	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—MAPK1—ovarian cancer	1.41e-05	0.000806	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—MAPK1—ovarian cancer	1.4e-05	0.0008	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—MAPK1—ovarian cancer	1.38e-05	0.000786	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NME2—ovarian cancer	1.35e-05	0.000773	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.34e-05	0.000767	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PPP1CC—ovarian cancer	1.27e-05	0.000723	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—BRIP1—ovarian cancer	1.27e-05	0.000723	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	1.26e-05	0.00072	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.24e-05	0.000706	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—HRAS—ovarian cancer	1.21e-05	0.00069	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—MAPK1—ovarian cancer	1.2e-05	0.000687	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.2e-05	0.000686	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—YAP1—ovarian cancer	1.17e-05	0.000671	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—HRAS—ovarian cancer	1.15e-05	0.000658	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.15e-05	0.000656	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—YAP1—ovarian cancer	1.14e-05	0.00065	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—HRAS—ovarian cancer	1.13e-05	0.000647	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.13e-05	0.000643	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—HRAS—ovarian cancer	1.13e-05	0.000643	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYTB—ovarian cancer	1.12e-05	0.000639	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—HRAS—ovarian cancer	1.1e-05	0.000631	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.1e-05	0.000625	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.09e-05	0.000625	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NME2—ovarian cancer	1.04e-05	0.000596	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYTB—ovarian cancer	1.03e-05	0.000588	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYTB—ovarian cancer	1.02e-05	0.000583	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.97e-06	0.00057	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.9e-06	0.000565	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—BRIP1—ovarian cancer	9.78e-06	0.000559	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PPP1CC—ovarian cancer	9.78e-06	0.000559	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—HRAS—ovarian cancer	9.66e-06	0.000552	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—FASN—ovarian cancer	9.57e-06	0.000547	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—SLC5A5—ovarian cancer	9.41e-06	0.000538	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.36e-06	0.000534	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—FASN—ovarian cancer	9.28e-06	0.00053	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—SLC5A5—ovarian cancer	9.13e-06	0.000521	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—SLC2A1—ovarian cancer	9.09e-06	0.000519	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—BRIP1—ovarian cancer	9e-06	0.000514	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PPP1CC—ovarian cancer	9e-06	0.000514	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—BRIP1—ovarian cancer	8.92e-06	0.000509	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PPP1CC—ovarian cancer	8.92e-06	0.000509	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—SLC2A1—ovarian cancer	8.81e-06	0.000503	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYTB—ovarian cancer	8.72e-06	0.000498	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP1B1—ovarian cancer	8.72e-06	0.000498	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.63e-06	0.000493	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.52e-06	0.000487	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—YAP1—ovarian cancer	8.49e-06	0.000485	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP1B1—ovarian cancer	8.45e-06	0.000483	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	7.73e-06	0.000442	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—BRIP1—ovarian cancer	7.62e-06	0.000435	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PPP1CC—ovarian cancer	7.62e-06	0.000435	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PPP2R1A—ovarian cancer	7.49e-06	0.000428	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.46e-06	0.000426	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—ABCB1—ovarian cancer	7.18e-06	0.00041	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.13e-06	0.000407	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—TYMS—ovarian cancer	7.05e-06	0.000403	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—ABCB1—ovarian cancer	6.96e-06	0.000397	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—FASN—ovarian cancer	6.92e-06	0.000395	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—TYMS—ovarian cancer	6.83e-06	0.00039	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—SLC5A5—ovarian cancer	6.81e-06	0.000389	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYTB—ovarian cancer	6.73e-06	0.000384	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—SLC2A1—ovarian cancer	6.57e-06	0.000375	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—YAP1—ovarian cancer	6.56e-06	0.000375	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.5e-06	0.000371	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.49e-06	0.000371	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP1B1—ovarian cancer	6.3e-06	0.00036	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—YAP1—ovarian cancer	6.03e-06	0.000345	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—YAP1—ovarian cancer	5.98e-06	0.000342	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.92e-06	0.000338	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.88e-06	0.000336	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.88e-06	0.000336	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.71e-06	0.000326	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CAV1—ovarian cancer	5.68e-06	0.000324	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	5.59e-06	0.000319	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.55e-06	0.000317	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CAV1—ovarian cancer	5.51e-06	0.000314	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—FASN—ovarian cancer	5.35e-06	0.000305	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—SLC5A5—ovarian cancer	5.26e-06	0.0003	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.26e-06	0.0003	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.2e-06	0.000297	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ABCB1—ovarian cancer	5.19e-06	0.000296	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CG—ovarian cancer	5.17e-06	0.000296	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—YAP1—ovarian cancer	5.11e-06	0.000292	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—TYMS—ovarian cancer	5.1e-06	0.000291	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—SLC2A1—ovarian cancer	5.08e-06	0.00029	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.06e-06	0.000289	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CG—ovarian cancer	5.02e-06	0.000286	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.98e-06	0.000284	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—FASN—ovarian cancer	4.92e-06	0.000281	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—FASN—ovarian cancer	4.88e-06	0.000279	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP1B1—ovarian cancer	4.87e-06	0.000278	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SLC5A5—ovarian cancer	4.84e-06	0.000276	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.8e-06	0.000274	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SLC2A1—ovarian cancer	4.67e-06	0.000267	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.63e-06	0.000265	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CD—ovarian cancer	4.55e-06	0.00026	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.54e-06	0.000259	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP1B1—ovarian cancer	4.48e-06	0.000256	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.45e-06	0.000254	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.44e-06	0.000254	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CD—ovarian cancer	4.41e-06	0.000252	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	4.32e-06	0.000247	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.3e-06	0.000246	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—FASN—ovarian cancer	4.17e-06	0.000238	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CAV1—ovarian cancer	4.11e-06	0.000235	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.1e-06	0.000234	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ABCB1—ovarian cancer	4.01e-06	0.000229	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	3.97e-06	0.000227	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CB—ovarian cancer	3.97e-06	0.000226	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.96e-06	0.000226	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—YAP1—ovarian cancer	3.95e-06	0.000225	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—TYMS—ovarian cancer	3.94e-06	0.000225	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.94e-06	0.000225	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.92e-06	0.000224	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.88e-06	0.000221	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CB—ovarian cancer	3.84e-06	0.000219	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.8e-06	0.000217	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CG—ovarian cancer	3.74e-06	0.000214	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.69e-06	0.000211	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.66e-06	0.000209	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—TYMS—ovarian cancer	3.62e-06	0.000207	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—TYMS—ovarian cancer	3.59e-06	0.000205	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTEN—ovarian cancer	3.43e-06	0.000196	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.37e-06	0.000192	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.35e-06	0.000191	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTEN—ovarian cancer	3.32e-06	0.00019	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CD—ovarian cancer	3.29e-06	0.000188	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—FASN—ovarian cancer	3.22e-06	0.000184	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CAV1—ovarian cancer	3.17e-06	0.000181	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.16e-06	0.000181	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.13e-06	0.000179	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—TYMS—ovarian cancer	3.07e-06	0.000175	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.06e-06	0.000175	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.03e-06	0.000173	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.93e-06	0.000167	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CAV1—ovarian cancer	2.92e-06	0.000167	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CAV1—ovarian cancer	2.89e-06	0.000165	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.89e-06	0.000165	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CB—ovarian cancer	2.87e-06	0.000164	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.77e-06	0.000158	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.66e-06	0.000152	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.64e-06	0.000151	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.6e-06	0.000148	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.54e-06	0.000145	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTEN—ovarian cancer	2.48e-06	0.000141	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CAV1—ovarian cancer	2.47e-06	0.000141	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.42e-06	0.000138	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.41e-06	0.000138	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—TYMS—ovarian cancer	2.37e-06	0.000135	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.36e-06	0.000135	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CA—ovarian cancer	2.34e-06	0.000134	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.34e-06	0.000134	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.32e-06	0.000132	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.25e-06	0.000129	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.22e-06	0.000127	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.04e-06	0.000116	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.02e-06	0.000115	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.98e-06	0.000113	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—AKT1—ovarian cancer	1.97e-06	0.000113	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTEN—ovarian cancer	1.91e-06	0.000109	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—AKT1—ovarian cancer	1.91e-06	0.000109	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CAV1—ovarian cancer	1.91e-06	0.000109	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTEN—ovarian cancer	1.76e-06	0.000101	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.75e-06	9.98e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTEN—ovarian cancer	1.75e-06	9.97e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.74e-06	9.93e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.73e-06	9.86e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.53e-06	8.73e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTEN—ovarian cancer	1.49e-06	8.52e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—AKT1—ovarian cancer	1.43e-06	8.15e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.35e-06	7.71e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.33e-06	7.61e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.24e-06	7.1e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.23e-06	7.03e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTEN—ovarian cancer	1.15e-06	6.58e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—AKT1—ovarian cancer	1.1e-06	6.3e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.05e-06	6.01e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—AKT1—ovarian cancer	1.01e-06	5.8e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—AKT1—ovarian cancer	1.01e-06	5.75e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—AKT1—ovarian cancer	8.6e-07	4.91e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.12e-07	4.64e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—AKT1—ovarian cancer	6.64e-07	3.79e-05	CbGpPWpGaD
